NeoGenomics, Inc
Price
FilingsNewest: 8-K, Results of operationsOct 5 →InsidersNo open-market buys. 3 insiders sold $695,596, all 5 sales on a 10b5-1 plan.→HoldersBlackRock 16.3%First Light 9.6%First Trust 7.9%→PeersClosest companies: MYGN, NTRA, WGS→
From the filings
Figures
- Revenue
- $766.3Mlast 12 months
- Net income
- −$51.9Mlast 12 months
- Operating cash flow
- $22.4Mlast 12 months
- Cash and equivalents
- $145.5Mat the last balance sheet
- Total debt
- $374.2Mat the last balance sheet
- Shares outstanding
- 127.9M shareson issue